We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Mouse Model for Study of Neurodegenerative Proteins

By Biotechdaily staff writers
Posted on 11 Nov 2003
Researchers have established a mouse model that allows them to study two proteins, p25 and cyclin-dependent kinase 5 (Cdk5), which are involved in the neuronal death and atrophy found in neurodegenerative diseases.

The long-lived p25 protein is generated in the brain by proteolytic cleavage of the p35 protein. More...
P25 activates Cdk5, and this combination has been found in the brain tissue of patients with neurodegenerative diseases such as Alzheimer's and Niemann-Pick type C. Investigators from Harvard Medical School (Boston, MA, USA) developed a line of mice with a gene for overproduction of p25. Expression of the gene was suppressed during brain development with doxycycline. The drug was removed when the mice matured, and the effects of p25 overexpression were determined.

Results published in the October 30, 2003, issue of Neuron showed that after only 12 weeks of p25 exposure, neuronal density in the mouse brains declined by 40%. By 30 weeks after p25 induction, aggregation of tau proteins caused neurofibrillary tangles in the brain, along with neurodegeneration and neuronal cell death.

"This is an excellent animal model for any therapeutic approach toward p25 and its link to Alzheimer's and similar neurodegenerative diseases,” explained senior author Dr. Li-Huei Tsai, professor of pathology at Harvard Medical School. "We know that p25 causes neurodegeneration, and we want to figure out how that mechanism works.”




Related Links:
Harvard Medical School

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Immunoassay Analyzer
Procise DX
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.